Orthocell LimitedASX: OCCOrthocell Limited is a regenerative medicine company focused on developing and commercialising biological medical technologies for tissue repair and healing. Its portfolio includes CelGro, a collagen-based medical device used in soft tissue repair, and Autologous Tenocyte Implantation (ATI), a cell therapy designed to treat chronic, treatment-resistant tendon injuries
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Emerging Growth Opportunities
A$199.00
Already a subscriber?
Sign in to read this report.
Required subscription
Emerging Growth Opportunities
Discover emerging ASX growth opportunities through weekly research focused on companies with strong expansion potential, business momentum, and long-term growth prospects.
- ✓ Emerging ASX Growth Stock Research
- ✓ Delivered Every Wednesday
- ✓ Growth Potential & Risk Ratings
- ✓ Full Historical Report Access
A$199.00A$750.00/ 12 months
Risk:Medium
Subscribe Now →
